Related Experiment Videos
Super-activated interferon-regulatory factors can enhance plasmid immunization
Jonathan L Bramson1, Kelley Dayball, Jennifer R Hall
1Department of Pathology and Molecular Medicine, Center for Gene Therapeutics, McMaster University, 1200 Main Street West, Hamilton, Ont., Canada L8N 3Z5. bramsonj@mcmaster.ca
Vaccine
|March 5, 2003
Summary
Super-activated interferon-regulatory factors (IRFs) significantly boost plasmid vaccine efficacy. These novel adjuvants dramatically enhanced immune responses, including cytotoxic T cells and antibodies, in preclinical models.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Interferon-regulatory factors (IRFs) play crucial roles in immune responses.
- Super-activated IRF variants, IRF-3(5D) and IRF7/3A, were previously identified through structure-function studies.
- Adjuvants are critical for enhancing the immunogenicity of genetic vaccines.
Purpose of the Study:
- To evaluate the adjuvant properties of super-activated IRF-3(5D) and IRF7/3A for plasmid vaccines.
- To assess the impact of these IRFs on cell-mediated and humoral immune responses.
- To determine the protective efficacy of vaccines incorporating these IRFs against viral challenge.
Main Methods:
- Plasmid DNA encoding IRF-3(5D) and IRF7/3A was constructed.
- Mice were immunized intramuscularly with plasmid cocktails containing either super-activated IRFs or a control.
- Cytotoxic T cell responses, antigen-specific antibody production, and protection against recombinant vaccinia virus challenge were measured.
Main Results:
- A single immunization with IRF-3(5D) and IRF7/3A plasmid cocktails induced cytotoxic T cell responses in over 80% of mice.
- In contrast, only 20% of mice in the control group showed a T cell response.
- More than 60% of mice immunized with super-activated IRFs developed antigen-specific antibodies, versus 0% in the control group.
- Vaccines incorporating super-activated IRFs conferred enhanced protection against vaccinia virus challenge.
Conclusions:
- Super-activated IRF-3(5D) and IRF7/3A demonstrate potent adjuvant properties for plasmid DNA vaccines.
- These IRFs significantly enhance both cellular and humoral immunity.
- The findings support the further development of these super-activated IRFs as novel adjuvants for genetic immunization strategies.